US HB2279 | 2019-2020 | 116th Congress
Status
Spectrum: Slight Partisan Bill (Democrat 105-53)
Status: Introduced on April 10 2019 - 25% progression, died in committee
Action: 2019-04-10 - Referred to the House Committee on Education and Labor.
Pending: House Education and Labor Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on April 10 2019 - 25% progression, died in committee
Action: 2019-04-10 - Referred to the House Committee on Education and Labor.
Pending: House Education and Labor Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Requires a group health plan to establish an exception to medication step-therapy protocol in specified cases. A medication step-therapy protocol establishes a specific sequence in which prescription drugs are covered by a group health plan or a health insurance issuer. A request for such an exception to the protocol must be granted if (1) the treatment is expected to be ineffective, (2) the treatment will cause or is likely to cause an adverse reaction to the individual, (3) the treatment is expected to decrease the individual's ability either to perform daily activities or occupational responsibilities or adhere to the treatment plan, (4) the individual is stable based on the prescription drugs already selected, or (5) there are other medical reasons that warrant withholding the treatment. The bill requires a group health plan to implement and make readily available a clear process for an individual to request an exception to the protocol. Requests must be granted no later than three days after receipt of the request. In certain cases where the life, health, and ability of the individual are jeopardized by the protocol, the request shall be granted no later than 24 hours after receipt of the request.
Title
Safe Step Act
Sponsors
History
Date | Chamber | Action |
---|---|---|
2019-04-10 | House | Referred to the House Committee on Education and Labor. |
2019-04-10 | House | Introduced in House |
Same As/Similar To
SB2546 (Related) 2019-09-25 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Subjects
Drug therapy
Employee benefits and pensions
Health
Health care costs and insurance
Health care coverage and access
Prescription drugs
Employee benefits and pensions
Health
Health care costs and insurance
Health care coverage and access
Prescription drugs
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/116th-congress/house-bill/2279/all-info |
Text | https://www.congress.gov/116/bills/hr2279/BILLS-116hr2279ih.pdf |